Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
13
×
archive
life sciences
national blog main
boston
boston blog main
boston top stories
clinical trials
medical
recalls
safety
alnylam pharmaceuticals
biotech
drugs
medicine
national top stories
patisiran
rna interference
alexion pharmaceuticals
deals
hereditary transthyretin amyloidosis
onpattro
paul matteis
san francisco blog main
san francisco top stories
acute hepatic porphyrias
akcea therapeutics
akin akinc
aminolevulinic acid
amyotrophic lateral sclerosis (als)
andrew fire
autoimmune disorders
blood pressure medication
boehringer ingelheim
cannabidiol
complement system
craig mello
crispr
cystic fibrosis
cystic fibrosis foundation
What
pharmaceuticals
13
×
drug
fda
recall
blood
pressure
announced
cancer
medication
recalled
expands
high
medicine
medicines
acella
ago
alnylam
approved
causing
consumers
disease
expanding
impurity
pharma
popular
potent
risk
rnai
thyroid
torrent
weeks
according
advised
advisory
afternoon
alembic
alerted
alnylam’s
alternative
approval
Language
unset
unknown
Current search:
fda
×
pharmaceuticals
×
@slashgear.com
2 years ago
Blood pressure and fluid retention drugs recalled over cancer concerns
@slashgear.com
2 years ago
Popular thyroid drug recalled because the pills aren’t potent enough
@slashgear.com
3 years ago
High blood pressure drug recalled because labels were mixed up
@slashgear.com
3 years ago
Popular thyroid drug recalled because it’s ‘super potent’ says FDA
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@bgr.com
4 years ago
FDA expands recall of blood pressure meds due to cancer-causing impurity
@slashgear.com
4 years ago
High blood pressure drug recall expands again over cancer risk
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@slashgear.com
4 years ago
Blood pressure medication recall expands over cancer risk
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug